Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU
Capri23auto / Pixabay

Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU

According to a story from Market Screener, the drug developer Albireo Pharma, Inc., recently announced that its investigational product candidate A4250 has earned Orphan Drug designation from the European Commission.…

Continue Reading Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU
14-Year-Old Aidan Needs a Liver Transplant to Treat Rare Biliary Atresia Condition
VSRao / Pixabay

14-Year-Old Aidan Needs a Liver Transplant to Treat Rare Biliary Atresia Condition

Aidan Maddocks, 14, from Pietermaritzburg, was diagnosed with Biliary Atresia at birth, a childhood liver disease that only affects 1 in 10,000–15,000 live births. He was given a life expectancy…

Continue Reading 14-Year-Old Aidan Needs a Liver Transplant to Treat Rare Biliary Atresia Condition
Close Menu